Bionano Genomics, Inc.
corporate_fare Company Profile
Bionano Genomics, Inc. (NASDAQ:BNGO) is a publicly traded company in the Industrial Applications And Services sector. Wiseek monitors BNGO SEC EDGAR filings and licensed market news in real time, scoring each submission for market-moving significance on a 1–10 scale. Items rated 7 or higher generate instant alerts.
Recent high-impact activity:
- Bionano Genomics Appoints Alex Hastie as Chief Scientific Officer
- Bionano's OGM Studies Surge 67% at ESHG 2026, Signaling Expanding Global Adoption
- Bionano Genomics CMO Resigns, Adding to Leadership Instability Amid Financial Woes
- Bionano Genomics CMO Resigns Amidst Ongoing Executive Turnover
- Bionano Genomics Repays $20M Senior Secured Convertible Debentures, Eliminating All Secured Debt
Financial Snapshot
Dilution Risk
Low riskFiling-implied dilution signals for BNGO, detected from its recent SEC filings.
New Universal Shelf Registration Filed · Addresses Going Concern Warning
A filing-implied signal, not a realized share count. How Wiseek tracks dilution →